Data compiled by Redley Lamar · ChainSifter Intelligence
6Suppliers
10Customers
1Debt Items
20Related Chains
Source-Backed Evidence Depth
Bio-Techne Corporation (TECH) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
18Total relationships
2Distinct source URLs
6High confidence
0.754Average confidence
2026-10-29Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Reciprocal relationship from TMO graph: Reciprocal relationship from TECH graph: we sell through a distribution agreement with Thermo Fisher Scientific
Reciprocal relationship from MDXH graph: Reciprocal relationship from TECH graph: Reciprocal relationship from MDXH graph: Reciprocal relationship from TECH graph: Reciprocal relationship from MDXH g…
Reciprocal relationship from ONCO graph: me of which possess substantially greater financial, selling, logistical and laboratory resources, more experience in dealing with third-party payors, and gre…
Reciprocal relationship from RENXF graph: t the aggregate outstanding $ million convertible loan notes into ordinary shares of VericiDx. As a result of the VericiDx IPO, the Company deconsolidated Ve…
Reciprocal relationship from XNCR graph: Reciprocal relationship from TECH graph: Reciprocal relationship from XNCR graph: old 8,093,712 shares of our common stock at the public offering price of $18…
Bio-Techne Corporation Customers
Ticker
Name
Confidence
Evidence
ACADEMIC-CUSTOMERS
ACADEMIC-CUSTOMERS
92%
Segment growth was driven by growth in consumable revenue to BioPharma (especially those developing cell and gene therapies) and Academic customers within the Americas and Europe
BIOPHARMA
BIOPHARMA
92%
Segment growth was driven by growth in consumable revenue to BioPharma (especially those developing cell and gene therapies)
pared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. These interim unaudited Condensed Consolidated Financial Statements s…
Reciprocal relationship from MDXH graph: Reciprocal relationship from TECH graph: pared in accordance with accounting principles generally accepted in the United States of America have been condensed…
Reciprocal relationship from ONCO graph: Reciprocal relationship from TECH graph: Reciprocal relationship from ONCO graph: Reciprocal relationship from TECH graph: Reciprocal relationship from ONCO g…
ACQUISITIONS-NAMOCELL-INC
ACQUISITIONS-NAMOCELL-INC
62%
. Amortization expense related to customer relationships is reflected in 67 Table of Contents selling, general and administrative expenses in the Consolidated Statement of Earnings and Comprehensive …
CHANGZHOU-EMINENCE-BIOTECHNOLOGY-CO-LTD
CHANGZHOU-EMINENCE-BIOTECHNOLOGY-CO-LTD
62%
excluding revenue from acquisitions within the preceding 12 months, the impact of foreign currency, the impact of businesses held-for-sale, as well as the impact of partially-owned consolidated subsi…
EQUITY-BIO-TECHNE-CORPORATION
EQUITY-BIO-TECHNE-CORPORATION
62%
excluding revenue from acquisitions within the preceding 12 months, the impact of foreign currency, the impact of businesses held-for-sale, as well as the impact of partially-owned consolidated subsi…
LUNAPHORE-TECHNOLOGIES
LUNAPHORE-TECHNOLOGIES
62%
of Contents Note 4 . Acquisitions: We periodically complete business combinations that align with our business strategy. Acquisitions are accounted for using the acquisition method of accounting, whi…
WILSON-WOLF-CORPORATION
WILSON-WOLF-CORPORATION
62%
. In applying ASC 805 to the transaction, the Company has elected to include Eminence in our consolidated financial statements on a one month lag. As noted below, Eminence was sold during the first f…
Bio-Techne Corporation Debt Obligations
Instrument
Description
Confidence
Evidence
TECH-DEBT
Debt stack $12.5M
90%
Market cache reports total debt of $12.5M.
Bio-Techne Corporation Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Bio-Techne Corporation.
Bio-Techne Corporation Ownership
Holder
Name
Confidence
Evidence
TECH-OWNER-MORGAN-STANLEY
MORGAN STANLEY
90%
13F overlay lists MORGAN STANLEY as top holder; 586 tracked holders.
